The regulatory requirements for capital markets participants are becoming increasingly stringent and consume inordinate amounts of time and capital.
At the heart of several wide-ranging regulatory initiatives – among them MiFID II, the Fundamental Review of the Trading Book (FRTB) and BCBS 239 – is the requirement for understanding the source, accuracy and veracity of the data they are using, whether to contribute to market transparency mechanisms, report trades or calculate banking and trading book risk.
Financial institutions need to be sure the data they are contributing, reporting or using for risk calculations has been quality-checked and is fit for purpose. To ensure success, firms need robust quality control and data governance at all points through the data generation, contribution and analysis workflow.
A data governance framework that ensures that regulatory data is free of gaps, stale data, outlier and other quality issues. CMS can help firms ensure consistency in the contributions across all asset classes to Approved Publication Arrangements (APAs) under MiFID II, or demonstrating evidence of modelable liquid prices under FRTB.
The pooling service allows banks and other independent data sources to aggregate their illiquid OTC derivatives prices, contributions, traded and transacted datasets, allowing them to ‘observe’ market risk regulatory capital rules, modeled in line with the requirements of FRTB.
We'd be delighted to discuss your particular challenges around regulation and how we might be able to meet them: